Literature DB >> 24170032

Host susceptibility to malaria in human and mice: compatible approaches to identify potential resistant genes.

Maria Hernandez-Valladares1, Pascal Rihet, Fuad A Iraqi.   

Abstract

There is growing evidence for human genetic factors controlling the outcome of malaria infection, while molecular basis of this genetic control is still poorly understood. Case-control and family-based studies have been carried out to identify genes underlying host susceptibility to malarial infection. Parasitemia and mild malaria have been genetically linked to human chromosomes 5q31-q33 and 6p21.3, and several immune genes located within those regions have been associated with malaria-related phenotypes. Association and linkage studies of resistance to malaria are not easy to carry out in human populations, because of the difficulty in surveying a significant number of families. Murine models have proven to be an excellent genetic tool for studying host response to malaria; their use allowed mapping 14 resistance loci, eight of them controlling parasitic levels and six controlling cerebral malaria. Once quantitative trait loci or genes have been identified, the human ortholog may then be identified. Comparative mapping studies showed that a couple of human and mouse might share similar genetically controlled mechanisms of resistance. In this way, char8, which controls parasitemia, was mapped on chromosome 11; char8 corresponds to human chromosome 5q31-q33 and contains immune genes, such as Il3, Il4, Il5, Il12b, Il13, Irf1, and Csf2. Nevertheless, part of the genetic factors controlling malaria traits might differ in both hosts because of specific host-pathogen interactions. Finally, novel genetic tools including animal models were recently developed and will offer new opportunities for identifying genetic factors underlying host phenotypic response to malaria, which will help in better therapeutic strategies including vaccine and drug development.

Entities:  

Keywords:  QT mapping; genetic resistance; human; malaria; mouse model

Mesh:

Year:  2013        PMID: 24170032     DOI: 10.1152/physiolgenomics.00044.2013

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  7 in total

1.  Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation.

Authors:  Ana Carolina Moreira Souza; Andrea Grabe-Guimarães; Jader Dos Santos Cruz; Artur Santos-Miranda; Charlotte Farah; Liliam Teixeira Oliveira; Alexandre Lucas; Franck Aimond; Pierre Sicard; Vanessa Carla Furtado Mosqueira; Sylvain Richard
Journal:  Br J Pharmacol       Date:  2020-08-24       Impact factor: 8.739

Review 2.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

3.  Autoimmune-Disease-Prone NOD Mice Help To Reveal a New Genetic Locus for Reducing Pulmonary Disease Caused by Mycoplasma pulmonis.

Authors:  Glenn F Browning; Thomas C Brodnicki; Nadeeka K Wawegama; Philip F Markham; Colleen M Elso; Anna Kanci; Marc S Marenda
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 4.  Genetic mapping of determinants in drug resistance, virulence, disease susceptibility, and interaction of host-rodent malaria parasites.

Authors:  Xin-Zhuan Su; Jian Wu; Fangzheng Xu; Sittiporn Pattaradilokrat
Journal:  Parasitol Int       Date:  2022-08-01       Impact factor: 2.106

5.  The genetic control of immunity to Plasmodium infection.

Authors:  Audrey V Grant; Christian Roussilhon; Richard Paul; Anavaj Sakuntabhai
Journal:  BMC Immunol       Date:  2015-03-26       Impact factor: 3.615

6.  Long-Term Prophylaxis and Pharmacokinetic Evaluation of Intramuscular Nano- and Microparticle Decoquinate in Mice Infected with P. berghei Sporozoites.

Authors:  Qigui Li; Lisa Xie; Diana Caridha; Qiang Zeng; Jing Zhang; Norma Roncal; Ping Zhang; Chau Vuong; Brittney Potter; Jason Sousa; Sean Marcsisin; Lisa Read; Mark Hickman
Journal:  Malar Res Treat       Date:  2017-04-13

7.  NCR3 polymorphism, haematological parameters, and severe malaria in Senegalese patients.

Authors:  Alassane Thiam; Sabrina Baaklini; Babacar Mbengue; Samia Nisar; Maryam Diarra; Sandrine Marquet; Mouhamadou Mansour Fall; Michel Sanka; Fatou Thiam; Rokhaya Ndiaye Diallo; Magali Torres; Alioune Dieye; Pascal Rihet
Journal:  PeerJ       Date:  2018-12-03       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.